Effect of Large Language Model in Assisting Discharge Summary Notes Writing for Hospitalized Patients

NCT06263855 | Withdrawn

• 1 other identifier: 24-000352
• Study Type: interventional
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

This pilot study aims to assess the feasibility of carrying out a full-scale pragmatic, cluster-randomized controlled trial which will investigate whether discharge summary writing assisted by a large language model (LLM), called CURE (Checker for Unvalidated Response Errors), improves care delivery without adversely impacting patient outcomes.

Conditions

Large Language Model

Outcome Measures

Primary Outcomes (1)

• Rate of patient accrual

  The first feasibility outcome will be the rate of patient accrual. An accrual of one patient per day will be considered acceptable, i.e., 91 patients discharged from a 91-day period who are appropriately randomized and can be included in the analyses.

  Three months

Study Arms (2)

Intervention

EXPERIMENTAL

Clinicians who care for patients randomized to intervention will have access to CURE to assist with discharge summary writing.

Other: CURE

Control

NO INTERVENTION

Clinicians who care for patients randomized to control will continue with standard practice for discharge summary writing.

Interventions

CURE OTHER

A large language model (LLM) to help clinicians prepare discharge summaries for hospitalized patients.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adult patients admitted to one of three participating cardiology services at Mayo Clinic in Rochester, MN

You may not qualify if:

• Minor patients (\<18)
• Patients admitted to a hospital service where CURE is not implemented
• CLINICIANS
• Clinicians who provide care to randomized patients included in this pilot
• Clinicians who do not provide care to randomized patients included in this pilot

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Study Officials

• Xiaoxi Yao

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: February 9, 2024
• First Posted: February 16, 2024
• Study Start: January 1, 2026
• Primary Completion (Estimated): July 1, 2026
• Study Completion (Estimated): October 1, 2026
• Last Updated: January 30, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)